Alpha Cognition to Present at LD Micro Main Event

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ACOG--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)(“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will be presenting at the 14th annual Main Event...

Click to view original post